Phio Pharmaceuticals Corp. logo
Phio Pharmaceuticals Corp. PHIO
$ 1.15 1.77%

Annual report 2025
added 03-05-2026

report update icon

Phio Pharmaceuticals Corp. Gross Profit 2011-2026 | PHIO

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
  • Raw materials and supplies
  • Wages of production personnel
  • Depreciation of equipment
  • Transportation and warehousing costs (if directly related to production)
Importance for business:
  • Assessing core business profitability
    If gross profit is declining, it may indicate rising production costs or falling sales.
  • Financial planning
    Gross profit is the basis for calculating other key metrics, such as operating and net profit.
  • Benchmarking against competitors
    Gross profit analysis helps compare the efficiency of different companies within the same industry.
  • Insights into pricing effectiveness
    If gross profit is low, the company may be pricing too low or failing to control costs effectively.
Reasons for a decline in gross profit:
  • Increase in raw material and supply costs
  • Rising production expenses
  • Price reductions due to competition
  • Decrease in sales volume
  • Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit Phio Pharmaceuticals Corp.

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - - 4.36 K - - - - 34 K 71 K 399 K 97 K -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
399 K 4.36 K 121 K

Gross Profit of other stocks in the Biotechnology industry

Issuer Gross Profit Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
-1.72 M - 5743.5 % $ 69.7 M canadaCanada
MorphoSys AG MorphoSys AG
MOR
180 M - 2.43 % $ 254 M germanyGermany
MannKind Corporation MannKind Corporation
MNKD
35.1 M $ 3.56 24.48 % $ 1.09 B usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
102 K - -10.17 % $ 12.2 K usaUSA
Bio-Techne Corporation Bio-Techne Corporation
TECH
790 M $ 47.41 -16.36 % $ 7.47 B usaUSA
United Therapeutics Corporation United Therapeutics Corporation
UTHR
2.8 B $ 596.76 4.29 % $ 26.4 B usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
-428 K - -18.52 % $ 27.3 M britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.52 B - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
5.51 M - 2.54 % $ 160 B franceFrance
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
12.1 - -1.52 % $ 24.7 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
774 M - - - russiaRussia
INmune Bio INmune Bio
INMB
-10.9 K $ 1.52 -1.3 % $ 37.6 M usaUSA
Exelixis Exelixis
EXEL
935 M $ 48.7 9.64 % $ 13.2 B usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
473 M $ 21.48 -3.89 % $ 3.56 B usaUSA
Fortress Biotech Fortress Biotech
FBIO
31 M - - $ 71.1 M usaUSA
Advaxis Advaxis
ADXS
90 K - -9.65 % $ 45.9 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
225 M $ 3.15 1.19 % $ 655 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
2.03 M - - $ 5.51 M israelIsrael
Aeterna Zentaris Aeterna Zentaris
AEZS
2.65 M - 5.93 % $ 314 M canadaCanada
CureVac N.V. CureVac N.V.
CVAC
-10.6 M - - $ 867 M germanyGermany
AIkido Pharma AIkido Pharma
AIKI
10 K - 1.93 % $ 17.4 M usaUSA
Aptinyx Aptinyx
APTX
1.56 K - -39.0 % $ 4.57 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
39.2 M - -0.23 % $ 916 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
-523 K - -11.43 % $ 502 K usaUSA
Aravive Aravive
ARAV
5.68 K - -13.39 % $ 1.45 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
1 K - 17.91 % $ 11.1 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
90 K - - $ 7.46 M israelIsrael
Завод ДИОД Завод ДИОД
DIOD
325 M - - - russiaRussia